Journal
JOURNAL OF IMMUNOLOGY
Volume 191, Issue 12, Pages 5807-5810Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1302187
Keywords
-
Categories
Funding
- National Institutes of Health [AI078908, AI095219, AT002782, AI082369, HL111113, HL117945, HL36110]
- Vinik family
Ask authors/readers for more resources
Leukotriene C-4 (LTC4) and its extracellular metabolites, LTD4 and LTE4, mediate airway inflammation. They signal through three specific receptors (type 1 cys-LT receptor [CysLT(1)R], CysLT(2)R, and GPR99) with overlapping ligand preferences. In this article, we demonstrate that LTC4, but not LTD4 or LTE4, activates mouse platelets exclusively through CysLT(2)R. Platelets expressed CysLT(1)R and CysLT(2)R proteins. LTC4 induced surface expression of CD62P by wildtype mouse platelets in platelet-rich plasma (PRP) and caused their secretion of thromboxane A(2) and CXCL4. LTC4 was fully active on PRP from mice lacking either CysLT(1)R or GPR99, but completely inactive on PRP from CysLT(2)R-null (Cysltr2(-/-)) mice. LTC4/CysLT(2)R signaling required an autocrine ADP-mediated response through P2Y(12) receptors. LTC4 potentiated airway inflammation in a platelet-and CysLT(2)R-dependent manner. Thus, CysLT(2)R on platelets recognizes LTC4 with unexpected selectivity. Nascent LTC4 may activate platelets at a synapse with granulocytes before it is converted to LTD4, promoting mediator generation and the formation of leukocyte-platelet complexes that facilitate inflammation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available